ELII: Preclinical Development of Novel Reickettsiosis Therapeutics Targeting EPAC1

Project: Other project

Project Details

StatusFinished
Effective start/end date4/10/14 → 3/31/19

Funding

  • UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON: $638,095.00